Please login to the form below

Not currently logged in
Email:
Password:

essential medicines

This page shows the latest essential medicines news and features for those working in and with pharma, biotech and healthcare.

AstraZeneca chief on Brexit: “it’s going to be really painful”

AstraZeneca chief on Brexit: “it’s going to be really painful”

Soriot also claims to be lowest paid CEO in sector. AstraZeneca’s stockpiling of medicines ahead of Brexit is a temporary safeguard at best, and shortages could follow if no customs ... Too much friction in that process could affect patients’ability

Latest news

  • MHRA cut out of regulatory work as Brexit looms MHRA cut out of regulatory work as Brexit looms

    An Observer article reports that the Medicines and Healthcare products Regulatory Agency (MHRA) was awarded just two contracts to serve as the lead assessor on new drug applications – out of an ... higher-than-expected reduction in headcount as it

  • Pfizer builds gap between pharma and consumer health units Pfizer builds gap between pharma and consumer health units

    There are other changes afoot as well. Innovative health is rebadged as innovative medicines and will absorb biosimilar drugs and sterile injectables – currently part of Pfizer’s essential health division spanning ... Meanwhile, essential health –

  • Improving childhood cancer survival rates in developing countries Improving childhood cancer survival rates in developing countries

    At least 50% of these could be cured using generic World Health Organization-recommended essential medicines, but at least 80, 000 die unnecessarily without access to such therapy. ... There are worries around the lack of access to worldwide essential

  • UCB launches online clinical trial tool UCB launches online clinical trial tool

    Nathalie Vandenbruaene, UCB’s global web manager, said: “As a science-driven company, UCB’s clinical studies are essential to developing new medicines.

  • WHO pilots scheme to make biosimilars available to poorer countries WHO pilots scheme to make biosimilars available to poorer countries

    First used for HIV therapies in 2001 the scheme has since been extended to cover a broad range of essential medicines. ... Biosimilars could be game-changers for access to medicines for certain complex conditions," said Suzanne Hill, WHO's director of

More from news
Approximately 3 fully matching, plus 46 partially matching documents found.

Latest Intelligence

  • The handover: Pfizer reshapes itself for a new era The handover: Pfizer reshapes itself for a new era

    The new autonomous units come into effect in January 2019, and will be called Innovative Medicines, Pfizer Established Medicines and Consumer Healthcare. ... Angela Hwang had headed the previous Essential Medicines division. She commented on the off-

  • Brexit Means Brexit Brexit Means Brexit

    Maintaining membership would, she said, assure a continuation of investment in innovative medicines in the UK. ... Making sure the supply of medicines is uninterrupted is essential to ensure patients in the UK and EU can get the medicines they need from

  • The real-world data conundrum The real-world data conundrum

    Regardless of what the actual total costs are, though, it is certain that, with very few exceptions, the era of blockbuster drugs is over and the demand for stratified medicines, affordable ... diseases. At a more fundamental level, though, availability

  • The EarthWorks: New ways to improve patient care The EarthWorks: New ways to improve patient care

    Improving access to medicines. Demonstrating value in the real world is now central and essential to a medicines value proposition. ... Oncology is a great example of this change, we are working on solutions that manage toxicities for specific medicines

  • Reaching new heights Reaching new heights

    More than 225 medicines will be introduced by 2020, with one-third focused on treating cancer. ... Emerging economies will be focused on providing access and essential medicines to those in need to close endemic healthcare gaps.

More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest appointments

  • EMA’s head of international affairs steps down EMA’s head of international affairs steps down

    The European Medicines Agency's (EMA) Emer Cooke has resigned as head of international affairs, to be replaced ad interim by Agnès Saint-Raymond. ... From mid-November, Cooke will take up the head of regulation of medicines and other health technologies

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
PharmiWeb Solutions

PharmiWeb Solutions creates, delivers and manages digital solutions for the pharmaceutical and healthcare segment. From digital marketing, to patient education...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics